1don MSN
A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...
Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...
An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...
Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...
New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...
1d
Clinical Trials Arena on MSNMSD to push for approval of HIV combo after Phase III successMSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy.
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
18h
Montgomery Advertiser on MSNAlabama still fighting HIV: 'In the South is where we have the majority of the problems':Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results